Alyson Handy
Physician Assistant · Rochester, NYNPI 1982634598
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 484 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,455, 4.5 times the $543 reported in 2021. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 484 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$992
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$862
- Phathom Pharmaceuticals, Inc.$480
- Ardelyx, Inc.$460
- plus $3K from 27 others
What the payments were for
- Food & beverage$8,38599%
- Education$1091%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 116 | $1,897 |
| Johnson & Johnson(2 entities) | 60 | $1,206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 54 | $992 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 78 | $862 |
| Phathom Pharmaceuticals, Inc. | 31 | $480 |
| Ardelyx, Inc. | 21 | $460 |
| Regeneron Healthcare Solutions, Inc. | 13 | $325 |
| Bristol Myers Squibb | 12 | $192 |
| Intercept Pharmaceuticals, Inc. | 13 | $190 |
| Ironwood Pharmaceuticals, Inc | 9 | $184 |
| Lilly USA, LLC | 10 | $167 |
| Ferring Pharmaceuticals Inc. | 7 | $156 |
| Merck | 5 | $138 |
| Sanofi | 5 | $135 |
| Braintree Laboratories, Inc. | 7 | $120 |
| Organon | 4 | $81 |
| Pfizer | 5 | $81 |
| Daiichi Sankyo Inc. | 3 | $74 |
| Blueprint Medicines Corporation | 3 | $72 |
| Sandoz | 3 | $72 |
| Madrigal Pharmaceuticals | 2 | $69 |
| Alnylam Pharmaceuticals Inc. | 3 | $65 |
| Gilead | 3 | $58 |
| Exact Sciences | 2 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $55 |
| Novo Nordisk | 2 | $54 |
| QOL Medical, LLC | 2 | $53 |
| Amgen | 2 | $50 |
| Fresenius Kabi USA, LLC | 2 | $45 |
| Boehringer Ingelheim | 2 | $41 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
How this compares
$8,495 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 70 | $137,984 |
| XifaxanRifaximin | 12 | $38,600 |
| LinzessLinaclotide | 36 | $38,342 |
| Mesalamine | 29 | $34,349 |
| PentasaMesalamine | 13 | $21,686 |
| Esomeprazole Magnesium | 193 | $15,281 |
| VoqueznaVonoprazan Fumarate | 11 | $10,304 |
| Mesalamine DrMesalamine | 18 | $9,901 |
| Famotidine | 574 | $9,569 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 52 | $7,986 |
| TrulancePlecanatide | 13 | $7,292 |
| Dexlansoprazole DrDexlansoprazole | 13 | $4,750 |
| Ursodiol | 13 | $3,708 |
| Colestipol Hcl | 49 | $3,414 |
| Colesevelam Hcl | 20 | $3,203 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $1,897 | $176,326106 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $862 | $45,89325 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $480 | $10,30411 claims |
| Braintree Laboratories, Inc.Sutab | $120 | $7,98652 claims |
| SandozLansoprazole | $72 | $74022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Rochester
- Jennifer ServentiRochester$160K
- Sarah EnslinRochester$74K
- Bridget SkinnerRochester$25K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.